CLL is characterized by the gradual accumulation of mature B cells expressing B-lineage-specific markers (CD19, CD20, CD23, and CD5 antigen) in lymphoid tissues, bone marrow, and peripheral blood (PB). The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.